- Home
- BZUN vs LENZ Comparison
BZUN vs LENZ Comparison
Compare BZUN & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZUN | LENZ |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | China | United States |
| Employees | 6762 | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.3M | 155.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BZUN | LENZ |
|---|---|---|
| Price | $2.90 | $5.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 240.6K | ★ 966.4K |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | $7.89 | $50.42 |
| Revenue Next Year | $6.16 | $197.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.07 | $4.68 |
| 52 Week High | $4.88 | $50.19 |
Technical Indicators
Market Signals| Indicator | BZUN | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 43.80 |
| Support Level | $2.61 | $4.68 |
| Resistance Level | $3.04 | $6.18 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 64.87 | 26.40 |
Price Performance
Historical ComparisonAbout BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.